Lilly and ProQR to Expand RNA Editing Collaboration : vimars

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and ProQR Therapeutics N.V. (Nasdaq: PRQR), today announced the expansion of their licensing and...

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Netherlands , Andrewc Adams , Prnewswire Eli Lilly , Exchange Commission , Instagram , Institute For Genetic Medicine , Linkedin , Facebook , Adenosine Deaminase Acting , Looking Statements , Eli Lilly And Company ,